A Clinical Study to evaluate the efficacy of skin Renew Peptide Retinol Serum for skin Brightening - NI

Honasa Consumer Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1) Gender: Non-pregnant, non-lactating female aged between 25 to 45.
•2) Subjects willing to give written informed consent
•3) Women of childbearing potential must have a negative urine pregnancy test prior to study entry.
•4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
•5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

•1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
•2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
•3. Have open sores or open lesions in the treatment area(s).
•4. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.
•5. Have participated in any interventional clinical trial in the previous 30 days.
•6. Have a known sensitivity to any of the constituents of the test product.
•7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
•8. Have a history of alcohol or illegal drug or substance abuse, or suspected alcohol or illegal drug or substance abuse in the past 2 years.

发起方

Honasa Consumer Ltd.